Overview

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

Status:
Completed
Trial end date:
2008-10-15
Target enrollment:
Participant gender:
Summary
ZPU-003 EXT is a 2-year extension study of ZPU-003 (NCT00882258) to determine the continued safety and efficacy of Proellex in women who have previously completed the double-blind portion of the study.
Phase:
Phase 2
Details
Lead Sponsor:
Repros Therapeutics Inc.